The DOI matches its Crossref record; 232 of the 232 references it cites were found in a registry or an index.
Sex differences in Parkinson’s disease
Open accessAbstract
Parkinson's disease (PD) displays a greater prevalence and earlier age at onset in men. This review addresses the concept that sex differences in PD are determined, largely, by biological sex differences in the NSDA system which, in turn, arise from hormonal, genetic and environmental influences. Current therapies for PD rely on dopamine replacement strategies to treat symptoms, and there is an urgent, unmet need for disease modifying agents. As a significant degree of neuroprotection against the early stages of clinical or experimental PD is seen, respectively, in human and rodent females compared with males, a better understanding of brain sex dimorphisms in the intact and injured NSDA system will shed light on mechanisms which have the potential to delay, or even halt, the progression of PD. Available evidence suggests that sex-specific, hormone-based therapeutic agents hold particular promise for developing treatments with optimal efficacy in men and women.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Chen, G., Bower, K. A., Ma, C., Fang, S., Thiele, C. J., & Luo, J. (2004) · The FASEB Journal · doi:10.1096/fj.04-1551fje · Cited by 310
RetractedEffects of stress throughout the lifespan on the brain, behaviour and cognition
Lupien, S. J., McEwen, B. S., Gunnar, M. R., & Heim, C. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2639 · Cited by 6,256
AKT/PKB signaling: navigating downstream
Manning, B. D., & Cantley, L. C. (2007) · Cell · doi:10.1016/j.cell.2007.06.009 · Cited by 6,115
Systematic review of levodopa dose equivalency reporting in Parkinson's disease
Tomlinson, C. L., Stowe, R., Patel, S., Rick, C., Gray, R., & Clarke, C. E. (2010) · Movement Disorders · doi:10.1002/mds.23429 · Cited by 4,219
Incidence of Parkinson's Disease: Variation by Age, Gender, and Race/Ethnicity
Van Den Eeden, S. K. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg068 · Cited by 1,747
Sex differences in HPA axis responses to stress: a review
Kudielka, B. M., & Kirschbaum, C. (2005) · Biological Psychology · doi:10.1016/j.biopsycho.2004.11.009 · Cited by 1,624
Why sex matters for neuroscience
Cahill, L. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1909 · Cited by 1,540
Estrogen Actions in the Central Nervous System1
McEwen, B. S., & Alves, S. E. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0365 · Cited by 1,358
The Mystery and Magic of Glia: A Perspective on Their Roles in Health and Disease
Barres, B. A. (2008) · Neuron · doi:10.1016/j.neuron.2008.10.013 · Cited by 1,352
Astrocytes are active players in cerebral innate immunity
Farina, C., Aloisi, F., & Meinl, E. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.01.005 · Cited by 1,304 · cited 1×
“In the early, activation stage of the innate immune response, microglia and to a lesser extent, the astrocytes, produce oxidative and pro-inflammatory (potentially harmful) mediators; this triggers the later, resolution phase of the immune response, involving production of anti-inflammatory (protective) factors as wel…”
BackgroundThe role of inflammation in CNS injury and disease
Lucas, S., Rothwell, N. J., & Gibson, R. M. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706400 · Cited by 1,272 · cited 1×
“In the early, activation stage of the innate immune response, microglia and to a lesser extent, the astrocytes, produce oxidative and pro-inflammatory (potentially harmful) mediators; this triggers the later, resolution phase of the immune response, involving production of anti-inflammatory (protective) factors as wel…”
BackgroundThe epidemiology of traumatic brain injury: a review
Bruns, J., & Hauser, W. A. (2003) · Epilepsia · doi:10.1046/j.1528-1157.44.s10.3.x · Cited by 1,271
Blum, D., Torch, S., Lambeng, N., Nissou, M.-F., Benabid, A.-L., Sadoul, R., & Verna, J.-M. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(01)00003-x · Cited by 1,246
Canet-Avilés, R. M., Wilson, M. A., Miller, D. W., Ahmad, R., McLendon, C., Bandyopadhyay, S., Baptista, M. J., Ringe, D., Petsko, G. A., & Cookson, M. R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402959101 · Cited by 1,116
Devi, L., Raghavendran, V., Prabhu, B. M., Avadhani, N. G., & Anandatheerthavarada, H. K. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710012200 · Cited by 1,080
Garcia-Segura, L. M., Azcoitia, I., & DonCarlos, L. L. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00025-3 · Cited by 938
Estradiol and the Developing Brain
McCARTHY, M. M. (2008) · Physiological Reviews · doi:10.1152/physrev.00010.2007 · Cited by 885 · cited 5×
“Regarding hormonal factors, it is well established that a transient perinatal rise in testosterone production by the developing testes is a principal factor in the masculinisation/defeminisation of rodent brain regions controlling reproduction and reproductive behaviours (McCarthy, 2008; Wilson and Davies, 2007; Arnol…”
BackgroundInfluentialImmunolocalization of Estrogen Receptor β in the Mouse Brain: Comparison with Estrogen Receptor α
Mitra, S. W., Hoskin, E., Yudkovitz, J., Pear, L., Wilkinson, H. A., Hayashi, S., Pfaff, D. W., Ogawa, S., Rohrer, S. P., Schaeffer, J. M., et al. (2003) · Endocrinology · doi:10.1210/en.2002-221069 · Cited by 856
Organizational and activational effects of sex steroids on brain and behavior: A reanalysis
ARNOLD, A. (1985) · Hormones and Behavior · doi:10.1016/0018-506x(85)90042-x · Cited by 804
Integrated Brain Circuits: Astrocytic Networks Modulate Neuronal Activity and Behavior
Halassa, M. M., & Haydon, P. G. (2010) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021909-135843 · Cited by 763
Gender differences in Parkinson's disease
Haaxma, C. A., Bloem, B. R., Borm, G. F., Oyen, W. J. G., Leenders, K. L., Eshuis, S., Booij, J., Dluzen, D. E., & Horstink, M. W. I. M. (2007) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.103788 · Cited by 741
SCHWARTING, R., & HUSTON, J. (1996) · Progress in Neurobiology · doi:10.1016/s0301-0082(96)00040-8 · Cited by 737
Gillies, G. E., & McArthur, S. (2010) · Pharmacological Reviews · doi:10.1124/pr.109.002071 · Cited by 733 · cited 6×
“…of the lesion, the strain and species of rodent and the treatment regimen (dose of estrogen used; period of hypoestrogenicity between ovariectomy and treatment), as well as sex (Gillies and McArthur, 2010a; Ferraz et al., 2008; Cordellini et al., 2011; Brinton, 2008; McArthur and Gillies, 2011).”
BackgroundMethodResultInfluentialSelf-citationParkinson disease: from pathology to molecular disease mechanisms
Dexter, D. T., & Jenner, P. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.01.018 · Cited by 707
Glial reactions in Parkinson's disease
McGeer, P. L., & McGeer, E. G. (2008) · Movement Disorders · doi:10.1002/mds.21751 · Cited by 701
Gender Differences in Dopaminergic Function in Striatum and Nucleus Accumbens
Becker, J. B. (1999) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(99)00168-9 · Cited by 700
Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress
Gautier, C. A., Kitada, T., & Shen, J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802076105 · Cited by 698
Are men at greater risk for Parkinson's disease than women?
Wooten, G. F. (2004) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.020982 · Cited by 695
The current and projected economic burden of Parkinson's disease in the United States
Kowal, S. L., Dall, T. M., Chakrabarti, R., Storm, M. V., & Jain, A. (2013) · Movement Disorders · doi:10.1002/mds.25292 · Cited by 667
Neurotrophic and neuroprotective actions of estrogen: Basic mechanisms and clinical implications
Brann, D. W., Dhandapani, K., Wakade, C., Mahesh, V. B., & Khan, M. M. (2007) · Steroids · doi:10.1016/j.steroids.2007.02.003 · Cited by 647
Neurodegenerative causes of death among retired National Football League players
Lehman, E. J., Hein, M. J., Baron, S. L., & Gersic, C. M. (2012) · Neurology · doi:10.1212/wnl.0b013e31826daf50 · Cited by 638
Estrogen Signaling through the Transmembrane G Protein–Coupled Receptor GPR30
Prossnitz, E. R., Arterburn, J. B., Smith, H. O., Oprea, T. I., Sklar, L. A., & Hathaway, H. J. (2008) · Annual Review of Physiology · doi:10.1146/annurev.physiol.70.113006.100518 · Cited by 590
The substantia nigra of the human brain
Damier, P., Hirsch, E. C., Agid, Y., & Graybiel, A. M. (1999) · Brain · doi:10.1093/brain/122.8.1421 · Cited by 578
Parkinson’s disease and parkinsonism in a longitudinal study: Two-fold higher incidence in men
Baldereschi, M., Di Carlo, A., Rocca, W. A., Vanni, P., Maggi, S., Perissinotto, E., Grigoletto, F., Amaducci, L., & Inzitari, D. (2000) · Neurology · doi:10.1212/wnl.55.9.1358 · Cited by 526
Neuroprotective effects of estrogens: potential mechanisms of action
Green, P. S., & Simpkins, J. W. (2000) · International Journal of Developmental Neuroscience · doi:10.1016/s0736-5748(00)00017-4 · Cited by 523
The 6-Hydroxydopamine model of parkinson’s disease
Simola, N., Morelli, M., & Carta, A. R. (2007) · Neurotoxicity Research · doi:10.1007/bf03033565 · Cited by 514
Classic and New Animal Models of Parkinson's Disease
Blesa, J., Phani, S., Jackson-Lewis, V., & Przedborski, S. (2012) · Journal of Biomedicine and Biotechnology · doi:10.1155/2012/845618 · Cited by 505
Oestrogen as a neuroprotective hormone
Behl, C. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn846 · Cited by 488
The Epigenetics of Sex Differences in the Brain: Figure 1.
McCarthy, M. M., Auger, A. P., Bale, T. L., De Vries, G. J., Dunn, G. A., Forger, N. G., Murray, E. K., Nugent, B. M., Schwarz, J. M., & Wilson, M. E. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3331-09.2009 · Cited by 483
Bezard, E., Dovero, S., Prunier, C., Ravenscroft, P., Chalon, S., Guilloteau, D., Crossman, A. R., Bioulac, B., Brotchie, J. M., & Gross, C. E. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-17-06853.2001 · Cited by 483
The genetics of sex differences in brain and behavior
Ngun, T. C., Ghahramani, N., Sánchez, F. J., Bocklandt, S., & Vilain, E. (2011) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2010.10.001 · Cited by 440
Parkinson's disease and exposure to agricultural work and pesticide chemicals
Semchuk, K. M., Love, E. J., & Lee, R. G. (1992) · Neurology · doi:10.1212/wnl.42.7.1328 · Cited by 439
Gender difference in neural response to psychological stress
Wang, J., Korczykowski, M., Rao, H., Fan, Y., Pluta, J., Gur, R. C., McEwen, B. S., & Detre, J. A. (2007) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nsm018 · Cited by 436
Glia: Initiators and progressors of pathology in Parkinson's disease
Halliday, G. M., & Stevens, C. H. (2011) · Movement Disorders · doi:10.1002/mds.23455 · Cited by 424
Noradrenergic mechanisms in neurodegenerative diseases: a theory
Marien, M. R., Colpaert, F. C., & Rosenquist, A. C. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.02.002 · Cited by 414
Gender differences in Parkinson's disease: Clinical characteristics and cognition
Miller, I. N., & Cronin‐Golomb, A. (2010) · Movement Disorders · doi:10.1002/mds.23388 · Cited by 405 · cited 3×
“For example, several studies suggest that females present with a milder PD phenotype, which is most notable in the early clinical stages, especially prior to the introduction of anti-parkinsonian medication (Shulman and Bhat, 2006; Haaxma et al., 2007; Miller and Cronin-Golomb, 2011).”
BackgroundChung, C. Y., Koprich, J. B., Siddiqi, H., & Isacson, O. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5427-08.2009 · Cited by 391
Estrogen actions in the central nervous system
McMillan, P. J., & Dorsa, D. M. (1999) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/00060793-199902000-00006 · Cited by 390
The healthy cell bias of estrogen action: mitochondrial bioenergetics and neurological implications
Brinton, R. D. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.07.003 · Cited by 385
Risk tables for parkinsonism and Parkinson’s disease
Elbaz, A., Bower, J. H., Maraganore, D. M., McDonnell, S. K., Peterson, B. J., Ahlskog, J. E., Schaid, D. J., & Rocca, W. A. (2002) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(01)00425-5 · Cited by 377
Dopamine transporters and neuronal injury
Miller, G. W., Gainetdinov, R. R., Levey, A. I., & Caron, M. G. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01379-6 · Cited by 371
Vegeto, E., Benedusi, V., & Maggi, A. (2008) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2008.04.001 · Cited by 355
Gainetdinov, R. R., Fumagalli, F., Jones, S. R., & Caron, M. G. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69031322.x · Cited by 353
Presymptomatic compensation in Parkinson's disease is not dopamine-mediated
Bezard, E., Gross, C. E., & Brotchie, J. M. (2003) · Trends in Neurosciences · doi:10.1016/s0166-2236(03)00038-9 · Cited by 350
Sex Differences in Striatal Dopamine Release in Healthy Adults
Munro, C. A., McCaul, M. E., Wong, D. F., Oswald, L. M., Zhou, Y., Brasic, J., Kuwabara, H., Kumar, A., Alexander, M., Ye, W., et al. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.01.008 · Cited by 350
A possible role for humoral immunity in the pathogenesis of Parkinson's disease
Orr, C. F., Rowe, D. B., Mizuno, Y., Mori, H., & Halliday, G. M. (2005) · Brain · doi:10.1093/brain/awh625 · Cited by 350
Merchenthaler, I., Lane, M. V., Numan, S., & Dellovade, T. L. (2004) · Journal of Comparative Neurology · doi:10.1002/cne.20128 · Cited by 343
Role of inflammation in neurodegenerative diseases
Minghetti, L. (2005) · Current Opinion in Neurology · doi:10.1097/01.wco.0000169752.54191.97 · Cited by 335
Direct Regulation of Adult Brain Function by the Male-Specific Factor SRY
Dewing, P., Chiang, C. W. K., Sinchak, K., Sim, H., Fernagut, P.-O., Kelly, S., Chesselet, M.-F., Micevych, P. E., Albrecht, K. H., Harley, V. R., et al. (2006) · Current Biology · doi:10.1016/j.cub.2006.01.017 · Cited by 327
Parkinson's disease--Part 1: Pathophysiology, symptoms, burden, diagnosis, and assessment.
Weintraub, D. A., Comella, C. L., & Horn, S. S. (2008) · PubMed · Cited by 314
Striatal dopamine transporters and cognitive functioning in healthy men and women
Mozley, L. H., Gur, R. C., Mozley, P. D., & Gur, R. E. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.9.1492 · Cited by 314
Increased risk of parkinsonism in women who underwent oophorectomy before menopause
Rocca, W. A., Bower, J. H., Maraganore, D. M., Ahlskog, J. E., Grossardt, B. R., de Andrade, M., & Melton, L. J. (2008) · Neurology · doi:10.1212/01.wnl.0000280573.30975.6a · Cited by 307
Lavalaye, J., Booij, J., Reneman, L., Habraken, J. B. A., & van Royen, E. A. (2000) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590000279 · Cited by 305
Impaired neurotransmission caused by overexpression of α-synuclein in nigral dopamine neurons
Lundblad, M., Decressac, M., Mattsson, B., & Björklund, A. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1200575109 · Cited by 292
Marinus, J. (2002) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.72.2.241 · Cited by 288
Gender-related differences in the burden of non-motor symptoms in Parkinson’s disease
Martinez-Martin, P., Falup Pecurariu, C., Odin, P., Hilten, J. J., Antonini, A., Rojo-Abuin, J. M., Borges, V., Trenkwalder, C., Aarsland, D., Brooks, D. J., et al. (2012) · Journal of Neurology · doi:10.1007/s00415-011-6392-3 · Cited by 282
Sexual dimorphism in environmental epigenetic programming
Gabory, A., Attig, L., & Junien, C. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.02.015 · Cited by 279
GPR30 Does Not Mediate Estrogenic Responses in Reproductive Organs in Mice
Otto, C., Fuchs, I., Kauselmann, G., Kern, H., Zevnik, B., Andreasen, P., Schwarz, G., Altmann, H., Klewer, M., Schoor, M., et al. (2009) · Biology of Reproduction · doi:10.1095/biolreprod.108.071175 · Cited by 278
Incidence of Parkinson's disease in Norway: the Norwegian ParkWest study
Alves, G., Muller, B., Herlofson, K., HogenEsch, I., Telstad, W., Aarsland, D., Tysnes, O.-B., Larsen, J. P., & for the Norwegian ParkWest study group (2009) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2008.168211 · Cited by 273
The effect of estrogen replacement on early Parkinson’s disease
Saunders-Pullman, R., Gordon-Elliott, J., Parides, M., Fahn, S., Saunders, H. R., & Bressman, S. (1999) · Neurology · doi:10.1212/wnl.52.7.1417 · Cited by 270
Chen, J.-Q., Cammarata, P. R., Baines, C. P., & Yager, J. D. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2009.06.001 · Cited by 264
Neurodegeneration and Inflammation in Parkinson's disease
Phani, S., Loike, J. D., & Przedborski, S. (2012) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(11)70064-5 · Cited by 263
The Impact of Gender and Estrogen on Striatal Dopaminergic Neurotoxicity
MILLER, D. B., ALI, S. F., O'CALLAGHAN, J. P., & LAWS, S. C. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb08230.x · Cited by 262
Rogers, J., Mastroeni, D., Leonard, B., Joyce, J., & Grover, A. (2007) · International Review of Neurobiology · doi:10.1016/s0074-7742(07)82012-5 · Cited by 260
Cross sectional prevalence survey of idiopathic Parkinson's disease and parkinsonism in London
Schrag, A., Ben-Shlomo, Y., & Quinn, N. P. (2000) · BMJ · doi:10.1136/bmj.321.7252.21 · Cited by 252
Sex, glia, and development: Interactions in health and disease
Schwarz, J. M., & Bilbo, S. D. (2012) · Hormones and Behavior · doi:10.1016/j.yhbeh.2012.02.018 · Cited by 247
Sex Differences in the Striatal Dopamine D2 Receptor Binding Characteristics in Vivo
Pohjalainen, T., Rinne, J. O., Någren, K., SyvÄlahti, E., & Hietala, J. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.6.768 · Cited by 247
Neuroprotective actions of sex steroids in Parkinson’s disease
Bourque, M., Dluzen, D. E., & Di Paolo, T. (2009) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2009.04.014 · Cited by 239
Heterogeneity in male to female risk for Parkinson's disease
Taylor, K. S. M., Cook, J. A., & Counsell, C. E. (2007) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.104695 · Cited by 238
Effects of gender on nigral gene expression and parkinson disease
Cantuti-Castelvetri, I., Keller-McGandy, C., Bouzou, B., Asteris, G., Clark, T. W., Frosch, M. P., & Standaert, D. G. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.02.009 · Cited by 234
Gender differences in methamphetamine use and responses: A review
Dluzen, D. E., & Liu, B. (2008) · Gender Medicine · doi:10.1016/s1550-8579(08)80005-8 · Cited by 232
Walker, Q. D., Rooney, M. B., Wightman, R. M., & Kuhn, C. M. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00500-x · Cited by 231
Estrogens: Trophic and Protective Factors in the Adult Brain
Wise, P. M., Dubal, D. B., Wilson, M. E., Rau, S. W., & Liu, Y. (2001) · Frontiers in Neuroendocrinology · doi:10.1006/frne.2000.0207 · Cited by 230
Partial lesion of the substantia nigra: relation between extent of lesion and rotational behavior
Carman, L. S., Gage, F. H., & Shults, C. W. (1991) · Brain Research · doi:10.1016/0006-8993(91)90835-j · Cited by 230
Postmenopausal Estrogen Use Affects Risk for Parkinson Disease
Currie, L. J., Harrison, M. B., Trugman, J. M., Bennett, J. P., & Wooten, G. F. (2004) · Archives of Neurology · doi:10.1001/archneur.61.6.886 · Cited by 226
Benedetti, M. D., Maraganore, D. M., Bower, J. H., McDonnell, S. K., Peterson, B. J., Ahlskog, J. E., Schaid, D. J., & Rocca, W. A. (2001) · Movement Disorders · doi:10.1002/mds.1170 · Cited by 223
Glia-neuron crosstalk in the neuroprotective mechanisms of sex steroid hormones
Garcia-Ovejero, D., Azcoitia, I., DonCarlos, L. L., Melcangi, R. C., & Garcia-Segura, L. M. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.12.018 · Cited by 221
Elucidating the Role of Gonadal Hormones in Sexually Dimorphic Gene Coexpression Networks
van Nas, A., GuhaThakurta, D., Wang, S. S., Yehya, N., Horvath, S., Zhang, B., Ingram-Drake, L., Chaudhuri, G., Schadt, E. E., Drake, T. A., et al. (2009) · Endocrinology · doi:10.1210/en.2008-0563 · Cited by 220
Neuronal Life-and-Death Signaling, Apoptosis, and Neurodegenerative Disorders
Mattson, M. P. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.1997 · Cited by 214
Parkinson disease, 10 years after its genetic revolution: Multiple clues to a complex disorder
Klein, C., & Schlossmacher, M. G. (2007) · Neurology · doi:10.1212/01.wnl.0000271880.27321.a7 · Cited by 211
Complex disease, gender and epigenetics
Kaminsky, Z., Wang, S., & Petronis, A. (2006) · Annals of Medicine · doi:10.1080/07853890600989211 · Cited by 209
Annexin A1: A Central Player in the Anti-Inflammatory and Neuroprotective Role of Microglia
McArthur, S., Cristante, E., Paterno, M., Christian, H., Roncaroli, F., Gillies, G. E., & Solito, E. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001095 · Cited by 209
Self-citationMorale, M. C., Serra, P. A., L’Episcopo, F., Tirolo, C., Caniglia, S., Testa, N., Gennuso, F., Giaquinta, G., Rocchitta, G., Desole, M. S., et al. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2005.07.060 · Cited by 207
Sex differences in striatal presynaptic dopamine synthesis capacity in healthy subjects
Laakso, A., Vilkman, H., Bergman, J. Ö., Haaparanta, M., Solin, O., Syvälahti, E., Salokangas, R. K. R., & Hietala, J. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01369-0 · Cited by 203
Estrogen improves motor disability in parkinsonian postmenopausal women with motor fluctuations
Tsang, K.-L., Ho, S.-L., & Lo, S.-K. (2000) · Neurology · doi:10.1212/wnl.54.12.2292 · Cited by 203
Rapid Estrogen Signaling in the Brain
Raz, L., Khan, M. M., Mahesh, V. B., Vadlamudi, R. K., & Brann, D. W. (2008) · Neurosignals · doi:10.1159/000111559 · Cited by 201 · cited 2×
“…or the more recently recognised G protein-coupled receptor, GPER1 (also termed GPR30), are covered in many extensive reviews (Bourque et al., 2012; McEwen and Alves, 1999; Brann et al., 2007; Wise et al., 2001; Garcia-Segura et al., 2001; Raz et al., 2008; Behl, 2002; Green and Simpkins, 2000).”
BackgroundAcute Stimulatory Effect of Estradiol on Striatal Dopamine Synthesis
Pasqualini, C., Olivier, V., Guibert, B., Frain, O., & Leviel, V. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65041651.x · Cited by 201
The end of gonad-centric sex determination in mammals
Arnold, A. P. (2012) · Trends in Genetics · doi:10.1016/j.tig.2011.10.004 · Cited by 200
Parkinson's disease: Evidence for environmental risk factors
Kieburtz, K., & Wunderle, K. B. (2013) · Movement Disorders · doi:10.1002/mds.25150 · Cited by 199
Castaneda, E., Whishaw, I., & Robinson, T. (1990) · The Journal of Neuroscience · doi:10.1523/jneurosci.10-06-01847.1990 · Cited by 192
The MPTP-lesioned non-human primate models of Parkinson’s disease. Past, present, and future
Fox, S. H., & Brotchie, J. M. (2010) · Progress in brain research · doi:10.1016/s0079-6123(10)84007-5 · Cited by 191
Kritzer, M. F., & Creutz, L. M. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2637-08.2008 · Cited by 191
Sex differences in the inflammatory response of primary astrocytes to lipopolysaccharide
Santos-Galindo, M., Acaz-Fonseca, E., Bellini, M. J., & Garcia-Segura, L. M. (2011) · Biology of Sex Differences · doi:10.1186/2042-6410-2-7 · Cited by 191
Murray, H. E., Pillai, A. V., McArthur, S. R., Razvi, N., Datla, K. P., Dexter, D. T., & Gillies, G. E. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00578-x · Cited by 189
Self-citationTherapeutic approaches to inflammation in neurodegenerative disease
Klegeris, A., McGeer, E. G., & McGeer, P. L. (2007) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3280adc943 · Cited by 186
Caffeine and risk of Parkinson’s disease in a large cohort of men and women
Palacios, N., Gao, X., McCullough, M. L., Schwarzschild, M. A., Shah, R., Gapstur, S., & Ascherio, A. (2012) · Movement Disorders · doi:10.1002/mds.25076 · Cited by 185
Quesada, A., Lee, B. Y., & Micevych, P. E. (2008) · Developmental Neurobiology · doi:10.1002/dneu.20609 · Cited by 185
Gender differences in Parkinson's disease
Shulman, L. M. (2007) · Gender Medicine · doi:10.1016/s1550-8579(07)80003-9 · Cited by 183
The control of sexual differentiation of the reproductive system and brain
Wilson, C. A., & Davies, D. C. (2007) · Reproduction · doi:10.1530/rep-06-0078 · Cited by 182
Gender differences in motor and non-motor symptoms among Sardinian patients with Parkinson's disease
Solla, P., Cannas, A., Ibba, F. C., Loi, F., Corona, M., Orofino, G., Marrosu, M. G., & Marrosu, F. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.07.026 · Cited by 178
Gender differences in Parkinson's disease.
Lyons, K. E., Hubble, J. P., Tröster, A. I., Pahwa, R., & Koller, W. C. (1998) · PubMed · Cited by 177
Nature of Inhibition of Mitochondrial Respiratory Complex I by 6‐Hydroxydopamine
Glinka, Y., Tipton, K. F., & Youdim, M. B. H. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66052004.x · Cited by 176
Barlow, B. K., Cory-Slechta, D. A., Richfield, E. K., & Thiruchelvam, M. (2007) · Reproductive Toxicology · doi:10.1016/j.reprotox.2007.01.007 · Cited by 176
The Biology of Human Sex Differences
Federman, D. D. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052529 · Cited by 170
Neuroprotective effects of estrogen upon the nigrostriatal dopaminergic system
Dluzen, D. E. (2000) · Journal of Neurocytology · doi:10.1023/a:1007117424491 · Cited by 169
Are XX and XY brain cells intrinsically different?
Arnold, A. P., & Burgoyne, P. S. (2004) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2003.11.001 · Cited by 166
Progressive Dopamine Neuron Loss in Parkinson's Disease: The Multiple Hit Hypothesis
Carvey, P. M., Punati, A., & Newman, M. B. (2006) · Cell Transplantation · doi:10.3727/000000006783981990 · Cited by 164
Striatal Responses to Partial Dopaminergic Lesion: Evidence for Compensatory Sprouting
Song, D. D., & Haber, S. N. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-13-05102.2000 · Cited by 163
G2019S leucine-rich repeat kinase 2 causes uncoupling protein-mediated mitochondrial depolarization
Papkovskaia, T. D., Chau, K.-Y., Inesta-Vaquera, F., Papkovsky, D. B., Healy, D. G., Nishio, K., Staddon, J., Duchen, M. R., Hardy, J., Schapira, A. H. V., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds244 · Cited by 163
Gender differences in Parkinson's disease symptom profile: Differences between gender and symptoms
Scott, B., Borgman, A., Engler, H., Johnels, B., & Aquilonius, S. M. (2000) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2000.102001037.x · Cited by 161
Risk of Parkinson disease in women: Effect of reproductive characteristics
Ragonese, P., D’Amelio, M., Salemi, G., Aridon, P., Gammino, M., Epifanio, A., Morgante, L., & Savettieri, G. (2004) · Neurology · doi:10.1212/wnl.62.11.2010 · Cited by 158
Boksa, P., & El-Khodor, B. F. (2003) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(03)00012-5 · Cited by 157
Gender and the Parkinson’s disease phenotype
Baba, Y., Putzke, J. D., Whaley, N. R., Wszołek, Z. K., & Uitti, R. J. (2005) · Journal of Neurology · doi:10.1007/s00415-005-0835-7 · Cited by 155
Šimunović, F., Yi, M., Wang, Y., Stephens, R. M., & Sonntag, K. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008856 · Cited by 153
Sex Differences in Extrastriatal Dopamine D2-Like Receptors in the Human Brain
Kaasinen, V., Någren, K., Hietala, J. A., Farde, L., & Rinne, J. O. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.2.308 · Cited by 151
Wise, P. M., Dubal, D. B., Rau, S. W., Brown, C. M., & Suzuki, S. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0014 · Cited by 148
Role of P450 Aromatase in Sex-Specific Astrocytic Cell Death
Liu, M., Hurn, P. D., Roselli, C. E., & Alkayed, N. J. (2006) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600331 · Cited by 147
Estrogen decreases corpus striatal neurotoxicity in response to 6-hydroxydopamine
Dluzen, D. E. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00630-6 · Cited by 143
Animal models of obstetric complications in relation to schizophrenia
Boksa, P. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.01.001 · Cited by 142
McArthur, S., McHale, E., & Gillies, G. E. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301277 · Cited by 133
Self-citationKlein, L. C., & Corwin, E. J. (2002) · Current Psychiatry Reports · doi:10.1007/s11920-002-0072-z · Cited by 128
Sex dimorphisms in the neuroprotective effects of estrogen in an animal model of Parkinson's disease
Gillies, G. E., Murray, H. E., Dexter, D. T., & McArthur, S. (2004) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2004.04.022 · Cited by 128
Self-citationEffect of reproductive factors and postmenopausal hormone use on the risk of Parkinson disease
Popat, R. A., Eeden, S. K. V. D., Tanner, C. M., McGuire, V. M., BERNSTEIN, A. L., Bloch, D. A., Leimpeter, A. D., & Nelson, L. M. (2005) · Neurology · doi:10.1212/01.wnl.0000171344.87802.94 · Cited by 126
Menstrual‐related fluctuations in Parkinson's disease
Quinn, N. P., & MARSDEN, C. D. (1986) · Movement Disorders · doi:10.1002/mds.870010112 · Cited by 126
McDermott, J. L., Liu, B., & Dluzent, D. E. (1994) · Experimental Neurology · doi:10.1006/exnr.1994.1034 · Cited by 123
Robinson, T. E., Castañeda, E., & Whishaw, I. Q. (1990) · Canadian Journal of Psychology/Revue Canadienne de Psychologie · doi:10.1037/h0084241 · Cited by 119
Is there a connection between estrogen and Parkinson’s disease?
Shulman, L. M. (2002) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(02)00014-7 · Cited by 118
Czech, D., Lee, J., Sim, H., Parish, C. L., Vilain, E. J. N., & Harley, V. R. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07782.x · Cited by 116
Ling, Z. D., Chang, Q., Lipton, J. W., Tong, C. W., Landers, T. M., & Carvey, P. M. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2003.12.017 · Cited by 115
Liu, X., Fan, X., Zhao, Y. G., Luo, G., Li, X., Li, R., & Le, W. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20583 · Cited by 115
Jenner, P. G., Morris, H. R., Robbins, T. W., Goedert, M., Hardy, J., Ben‐Shlomo, Y., Bolam, J. P., Burn, D. J., Hindle, J. V., Brooks, D. J., et al. (2013) · Journal of Parkinson s Disease · doi:10.3233/jpd-130175 · Cited by 114
Estrogen: A multifunctional messenger to nigrostriatal dopaminergic neurons
Küppers, E., Ivanova, T., Karolczak‐Bayatti, M., & Beyer, C. (2000) · Journal of Neurocytology · doi:10.1023/a:1007165307652 · Cited by 107
Estrogen as Neuroprotectant of Nigrostriatal Dopaminergic System: Laboratory and Clinical Studies
Dluzen, D. E., & Horstink, M. W. I. M. (2003) · Endocrine · doi:10.1385/endo:21:1:67 · Cited by 105
Hernández-Baltazar, D., Mendoza‐Garrido, M. E., & Martínez‐Fong, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070951 · Cited by 104
Oestrogen and immunomodulation: new mechanisms that impact on peripheral and central immunity
Nadkarni, S., & McArthur, S. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.05.007 · Cited by 103
Zhu, K., van Hilten, J. J., Putter, H., & Marinus, J. (2013) · Movement Disorders · doi:10.1002/mds.25389 · Cited by 102
Gender disparities in Parkinson’s disease
Shulman, L. M., & Bhat, V. (2006) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.6.3.407 · Cited by 100
Liu, B., & Dluzen, D. E. (2007) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2007.04616.x · Cited by 98
Reactive astrocytes express estrogen receptors in the injured primate brain
Blurton-Jones, M. M., & Tuszynski, M. H. (2001) · The Journal of Comparative Neurology · doi:10.1002/cne.1129 · Cited by 96
Pons, D. G., Nadal‐Serrano, M., Blanquer-Rosselló, M. D. M., Sastre‐Serra, J., Oliver, J., & Roca, P. (2013) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24737 · Cited by 95
Naftolin, F. N., García‐Segura, L. M., Horváth, T. L., Zsarnovszky, A., Demır, N., Fadiel, A., Léránth, C., Vondracek-Klepper, S., Lewis, C., Chang, A. S., et al. (2007) · Reproductive Sciences · doi:10.1177/1933719107301059 · Cited by 94
Repeated Estradiol Treatment Prevents MPTP-Induced Dopamine Depletion in Male Mice
Ramirez, A. D., Liu, X., & Menniti, F. S. (2003) · Neuroendocrinology · doi:10.1159/000070277 · Cited by 93
GSK-3 mouse models to study neuronal apoptosis and neurodegeneration
Gómez‐Sintes, R., Hernández, F., Lucas, J. J., & Avila, J. (2011) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2011.00045 · Cited by 91
Pavon, J. M., Whitson, H. E., & Okun, M. S. (2010) · Maturitas · doi:10.1016/j.maturitas.2010.01.001 · Cited by 90
Håkansson, A., Westberg, L., Nilsson, S., Buervenich, S., Carmine, A., Holmberg, B., Sydow, O., Olson, L., Johnels, B., Eriksson, E., et al. (2005) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30136 · Cited by 90
Yu, L., & Liao, P. (2000) · Journal of Neural Transmission · doi:10.1007/s007020070084 · Cited by 89
Gillies, G. E., & McArthur, S. (2009) · Hormones and Behavior · doi:10.1016/j.yhbeh.2009.06.002 · Cited by 89
Self-citationPatterns of psychological problems in Parkinson's disease
Macht, M. L., Schwarz, R., & Ellgring, H. (2005) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2005.00375.x · Cited by 88
Wang, S. Z., Yan, J.-Y., Lo, Y.-K., Carvey, P. M., & Ling, Z. (2009) · Brain Research · doi:10.1016/j.brainres.2009.02.022 · Cited by 86
Leiknes, I., Tysnes, O., Aarsland, D., & Larsen, J. O. (2010) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2010.01332.x · Cited by 85
Bronstein, J. M., Carvey, P. M., Chen, H., Cory‐Slechta, D. A., Monte, D. A. D., Duda, J. E., English, P. B., Goldman, S. M., Grate, S. J., Hansen, J., et al. (2008) · Environmental Health Perspectives · doi:10.1289/ehp.11702 · Cited by 85
Méndez, P., Azcoitia, Í., & García‐Segura, L. M. (2005) · Journal of Endocrinology · doi:10.1677/joe.1.06058 · Cited by 84
Kipp, M., Karakaya, S., Johann, S., Kampmann, E., Mey, J., & Beyer, C. (2007) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2007.01588.x · Cited by 83
Serova, L. I., Maharjan, S., Huang, A., Sun, D., Kaley, G., & Sabban, E. L. (2004) · Brain Research · doi:10.1016/j.brainres.2004.04.002 · Cited by 82
Role of astroglia in the neuroplastic and neuroprotective actions of estradiol
Azcoitia, Í., Santos‐Galindo, M., Arévalo, M., & García‐Segura, L. M. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07516.x · Cited by 78
Baraka, A., Korish, A. A., Soliman, G. A., & Kamal, H. (2011) · Life Sciences · doi:10.1016/j.lfs.2011.03.010 · Cited by 76
Tamás, A., Lubics, A., Szalontay, L., Lengvári, I., & Reglődi, D. (2004) · Behavioural Brain Research · doi:10.1016/j.bbr.2004.09.002 · Cited by 76
Gonadal hormones and the control of reactive gliosis
Arévalo, M., Santos‐Galindo, M., Acaz‐Fonseca, E., Azcoitia, Í., & García‐Segura, L. M. (2012) · Hormones and Behavior · doi:10.1016/j.yhbeh.2012.02.021 · Cited by 74
Ábrahám, I. M., & Herbison, A. E. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2004.10.046 · Cited by 73 · cited 2×
“…out, because evidence suggests that intracellular signalling pathways may be sexually differentiated as a result of perinatal exposure to raised endogenous estradiol levels, after aromatisation of testosterone, in males, at least in the hypothalamus (Abraham and Herbison, 2005; Auger et al., 2001).”
BackgroundThanky, N. R., Son, J. H., & Herbison, A. E. (2002) · Molecular Brain Research · doi:10.1016/s0169-328x(02)00383-2 · Cited by 71
Coping processes and health‐related quality of life in Parkinson's disease
Bucks, R. S., Cruise, K., Skinner, T. C., Loftus, A. M., Barker, R., & Thomas, M. G. (2010) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2520 · Cited by 71
Sex differences in hypothalamic astrocyte response to estradiol stimulation
Kuo, J., Hamid, N., Bondar, G., Dewing, P., Clarkson, J., & Micevych, P. E. (2010) · Biology of Sex Differences · doi:10.1186/2042-6410-1-7 · Cited by 71
McArthur, S., Murray, H. E., Dhankot, A., Dexter, D. T., & Gillies, G. E. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04226.x · Cited by 70
Self-citationDluzen, D. E. (1996) · Brain Research · doi:10.1016/0006-8993(95)01566-3 · Cited by 70
Estrogens and the Pathophysiology of Parkinson's Disease
Sandyk, R. (1989) · International Journal of Neuroscience · doi:10.3109/00207458908986223 · Cited by 69
Differences in dopaminergic neuroprotective effects of estrogen during estrous cycle
Datla, K. P., Murray, H. E., Pillai, A. V., Gillies, G. E., & Dexter, D. T. (2003) · Neuroreport · doi:10.1097/00001756-200301200-00009 · Cited by 68
Self-citationYu, Y. L., & Wagner, G. C. (1994) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02260942 · Cited by 68
Liu, Fan, Xl, Zhao, Luo, Li, Xp, Le, †., & Wd (2006) · 中国生物学文摘 · Cited by 67
Yu, L., & Liao, P. (2000) · Journal of Neural Transmission · doi:10.1007/s007020070027 · Cited by 65
Implication of GPER1 in neuroprotection in a mouse model of Parkinson's disease
Bourque, M., Morissette, M., Côté, M., Soulet, D., & Paolo, T. D. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.05.022 · Cited by 65
Glia as a Turning Point in the Therapeutic Strategy of Parkinsons Disease
L’Episcopo, F., Tirolo, C., Testa, N., Caniglia, S., Morale, M. C., & Marchetti, B. (2010) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152710791292639 · Cited by 62
Implications for Estrogens in Parkinson's Disease: An Epidemiological Approach
Ragonese, P., D’Amelio, M., & Savettieri, G. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1386.004 · Cited by 62
Chronic estrogen treatment replaces striatal dopaminergic function in ovariectomized rats
Ohtani, H., Nomoto, M., & Douchi, T. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02276-4 · Cited by 61
Shughrue, P. J. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.08.009 · Cited by 58
Gender ratio differences between Parkinson's disease patients and their affected relatives
Swerdlow, R. H., Parker, W. D., Currie, L. J., Bennett, J. P., Harrison, M., Trugman, J. M., & Wooten, G. F. (2001) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(00)00029-8 · Cited by 58
Association between the estrogen receptor beta gene and age of onset of Parkinson’s disease
Westberg, L., Håkansson, A., Melke, J., Shahabi, H. N., Nilsson, S., Buervenich, S., Belin, A. C., Ahlberg, J., Grundell, M., Schulhof, B., et al. (2003) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2003.08.010 · Cited by 56
Auger, A. P., Hexter, D. P., & McCarthy, M. M. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03151-6 · Cited by 54
Gender differences and estrogen effects in parkin null mice
Rodríguez‐Navarro, J. A., Solano, R. M., Casarejos, M. J., Gómez, A., Perucho, J., de Yébenes, J. G., & Mena, M. A. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05569.x · Cited by 54
Injury-Induced Regulation of Steroidogenic Gene Expression in the Cerebellum
Mirzatoni, A., Spence, R. D., Naranjo, K. C., Saldanha, C. J., & Schlinger, B. A. (2010) · Journal of Neurotrauma · doi:10.1089/neu.2010.1330 · Cited by 54
Palacios, N., Weisskopf, M. G., Simon, K., Gao, X., Schwarzschild, M. A., & Ascherio, A. (2010) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2010.02.012 · Cited by 53
Gao, X., & Dluzen, D. E. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03221-2 · Cited by 53
Riccardi, P., Park, S., Anderson, S., Doop, M. L., Ansari, M. S., Schmidt, D. E., & Baldwin, R. M. (2010) · Synapse · doi:10.1002/syn.20822 · Cited by 51
Sex differences in methamphetamine toxicity in mice: Effect on brain dopamine signaling pathways
Bourque, M., Liu, B., Dluzen, D. E., & Paolo, T. D. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.12.007 · Cited by 50
Phytoestrogens induce apoptosis through a mitochondria/caspase pathway in human breast cancer cells
Chen, F., & Chien, M. (2013) · Climacteric · doi:10.3109/13697137.2013.869671 · Cited by 48
Callier, S., Saux, M. L., Lhiaubet, A., Paolo, T. D., Rostène, W. H., & Pélaprat, D. (2002) · Journal of Neurochemistry · doi:10.1046/j.0022-3042.2001.00693.x · Cited by 48
Disshon, K. A., & Dluzen, D. E. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02329-5 · Cited by 47
Whitworth, S. R., Loftus, A. M., Skinner, T. C., Gasson, N., Barker, R. A., Bucks, R. S., & Thomas, M. G. (2013) · Journal of Parkinson s Disease · doi:10.3233/jpd-120149 · Cited by 47
Boyalla, S. S., Victor, M. B., Roemgens, A., Beyer, C., & Arnold, S. (2011) · Journal of Neuroscience Research · doi:10.1002/jnr.22669 · Cited by 46
Estrogen and sequential movement.
Jennings, P. J., Janowsky, J. S., & ORWOLL, E. S. (1998) · Behavioral Neuroscience · doi:10.1037//0735-7044.112.1.154 · Cited by 45
Marchetti, B., Serra, P. A., L’Episcopo, F., Tirolo, C., Caniglia, S., Testa, N., S, C., Gennuso, F., Rocchitta, G., Desole, M. S., et al. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1356.023 · Cited by 44
Cited by
Balestrino, R., & Schapira, A. H. V. (2020) · European Journal of Neurology · doi:10.1111/ene.14108 · Cited by 1,508
Astrocyte reactivity and reactive astrogliosis: costs and benefits
Pekny, M., & Pekna, M. (2014) · Physiological Reviews · doi:10.1152/physrev.00041.2013 · Cited by 934
Considering sex and gender in Alzheimer disease and other dementias
Podcasy, J. L., & Epperson, C. N. (2016) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2016.18.4/cepperson · Cited by 707
Su, D., Cui, Y., He, C., Yin, P., Bai, R., Zhu, J., Lam, J. S. T., Zhang, J., Yan, R., Zheng, X., et al. (2025) · BMJ · doi:10.1136/bmj-2024-080952 · Cited by 611
Parkinson's Disease and the Environment
Ball, N., Teo, W.-P., Chandra, S., & Chapman, J. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00218 · Cited by 480
Metadata
- Authors
- Gillies, G. E., Pienaar, I. S., Vohra, S., & Qamhawi, Z.
- Venue
- Frontiers in Neuroendocrinology
- Publisher
- Elsevier BV
- Published
- 2014-08
- Volume
- 35
- Issue
- 3
- Pages
- 370-384
- ISSN
- 0091-3022 (ISSN-L)
- OpenAlex
- W1993241967
- Cited by
- 489
- References
- 232
- FWCI
- 17.07
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.